0001209191-22-047431.txt : 20220824
0001209191-22-047431.hdr.sgml : 20220824
20220824210120
ACCESSION NUMBER: 0001209191-22-047431
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220731
FILED AS OF DATE: 20220824
DATE AS OF CHANGE: 20220824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Castagna Michael
CENTRAL INDEX KEY: 0001674282
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50865
FILM NUMBER: 221192774
MAIL ADDRESS:
STREET 1: 25134 RYE CANYON LOOP
STREET 2: SUITE 300
CITY: VALENCIA
STATE: CA
ZIP: 91355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MANNKIND CORP
CENTRAL INDEX KEY: 0000899460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133607736
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CASPER STREET
CITY: DANBURY
STATE: CT
ZIP: 06810
BUSINESS PHONE: 818-661-5000
MAIL ADDRESS:
STREET 1: 1 CASPER STREET
CITY: DANBURY
STATE: CT
ZIP: 06810
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-07-31
2022-08-01
0
0000899460
MANNKIND CORP
MNKD
0001674282
Castagna Michael
1 CASPER STREET
DANBURY
CT
06810
1
1
0
0
Chief Executive Officer
Common Stock, $0.01 Par Value
2022-07-31
4
A
0
3147
2.93
A
2084486
D
This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective July 31, 2022.
/s/ Michael Castagna
2022-08-24